Glycemic index testing of beverage-meal replacement and a herbal paste

Not Applicable

• Registration Number: CTRI/2022/08/044890
• Lead Sponsor: Madras Diabetes Research Foundation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

BMI more than 18.5 to less than 22.9 kg/ m2 (as per WHO cut off for normal BMI)

Willingness to consume the test foods

no known food allergy or intolerance;

no medications known to affect glucose tolerance (excluding oral contraceptives) � stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable.

Exclusion Criteria

a known history of diabetes mellitus or the use of anti-hyperglycemic drugs or insulin to treat diabetes and related conditions

pregnant or lactating women

a major medical or surgical event requiring hospitalization within the preceding 3 months;

the presence of disease or drug(s) which influence digestion and absorption of nutrients;

the use of steroids, protease inhibitors or antipsychotics (all of which have major effects on glucose metabolism and body fat distribution).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Glycemic index and response of meal replacements and herbal paste compared to reference glucoseTimepoint: Capillary blood samples will be collected at 0 min- fasting and 4 times at an interval of 15 mins-15,30,45,60 mins and 2 times at interval of half an hour-90 and 120 mins for each test and reference food to determine the glycemic index.

Secondary Outcome Measures

Name	Time	Method
ilTimepoint: Nil